Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal Pathlabs has informed that it enclosed the details of proposed schedule of Analyst/ Institutional Investor meeting(s). Dates of the aforesaid meeting/call/ are subject to change due to exigencies on the part of Investor / Company. No Unpublished Price Sensitive Information will be shared during the meetings.
The above information is a part of company’s filings submitted to BSE.